Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS GPCR Consortium, an International Partnership of Industry and Academia, Established: Ono
October 30, 2014
-
ORGANIZATION JPMA to Launch Compound Library Joint Purchasing Initiative; Full-Scale Purchasing to Begin in FY2015
October 29, 2014
-
BUSINESS Pfizer Japan Gearing Up for Reorganization in December, Pres. Umeda to Double as Head of New Unit
October 28, 2014
-
BUSINESS Japan Arm of Hengrui Medicine Files Campto Generic for Approval
October 27, 2014
-
REGULATORY Chuikyo Begins Discussions on Patient-Initiated Mixed-Care System
October 24, 2014
-
REGULATORY Online Document Filings for Healthcare Product Import/Export Possible from November
October 23, 2014
-
ORGANIZATION Japan CRO Association Nearing Remote Verification Agreement with Cancer Treatment Center
October 22, 2014
-
REGULATORY Health Ministry Eyes Future Genomic Data Registration at National Medical Centers
October 21, 2014
-
BUSINESS Astellas to End License Agreement with US Venture Company for AD Treatments
October 20, 2014
-
BUSINESS Bayer AG Aims to Achieve Japan Sales of 300 Billion Yen by 2017
October 17, 2014
-
REGULATORY NIBIO to Begin Drug Seed Optimization Project from FY2015
October 16, 2014
-
REGULATORY 4 Die after Taking SGLT-2 Inhibitors, Causality under Scrutiny
October 15, 2014
-
BUSINESS Parexel CEO Hails Rise of Partnership-Based Outsourcing in Japan
October 14, 2014
-
ACADEMIA St. Marianna Hospital Elbows Drug Makers to Reveal Detailing Costs Embedded in Drug Prices
October 10, 2014
-
BUSINESS GSK to Market Authorized Generics through Aspen Japan Unit
October 10, 2014
-
REGULATORY MOF Panel to Pitch Reference Pricing for Long-Listed Drugs, Price Cut in FY2015
October 9, 2014
-
BUSINESS Shire Japan Takes Aim at $500 Million Sales in 10 Years
October 8, 2014
-
BUSINESS Chugai, Roche Chiefs Were in Talks on Recent Deal Change from 2 Years Ago
October 7, 2014
-
BUSINESS JCR Pharmaceuticals Hopes to Make Japan’s First Cell Product into New Profit Pillar
October 6, 2014
-
ORGANIZATION JPMA Plans Disclosure of Recipients, Amount of Payments for R&D Outlays
October 3, 2014
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…